{
    "code": "01001153",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01001153",
    "time": "2020-02-25 01:34:49",
    "許可證字號": "衛署藥製字第001153號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/05\/25",
    "發證日期": "61\/06\/12",
    "許可證種類": "製　劑",
    "舊證字號": "00000000",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00100115306",
    "中文品名": "噴通點鼻液",
    "英文品名": "PEN TUNG NAZAL SPRAY",
    "適應症": "因感冒而引起之鼻塞、鼻炎、肥厚性鼻炎等所引起之鼻充血",
    "劑型": "404鼻用噴液劑",
    "包裝": "瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "0309321200  三洋藥品工業股份有限公司大發廠",
        "申請商地址": "高雄市大寮區大寮村華西路４５號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400000810",
            "成分名稱": "CHLORPHENIRAMINE MALEATE",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1212001910",
            "成分名稱": "NAPHAZOLINE HCL",
            "含量描述": "0.5",
            "含量": "0.5000000000",
            "單位": "MG"
        }
    ]
}